NZT Noted .. our pills are not "prototypes", but are ready for sale.
Yes ... and Roger filled in another piece of the equation in a quote last year:‘‘... it’s very cheap to make so it will be quite an acceptable product on a cost basis.’’
https://pharmaust.com/hope-on-the-horizon-for-chemo-alternative/
Deciphering Roger speak (which I really like) ... we are sitting on a high margin product. A big attraction to Elanco and VIP to the negotiated $ values / royalty %.
Ok boys, go fetch.
The Turning Point, page-29
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $91.22M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $496.9K | 2.503M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49293 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 187198 | 4 |
View Market Depth
| Last trade - 12.52pm 25/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |